|
|
|
|
|
|
The CardioPump
allows the standard
method of external
chest compressions
to be enhanced with
active expansion of
the chest between
each compression
which increases the
intrathoracic volume
before compression
is started and
thereby improves
cardiac output
during the
compression phase.
The
CardioPump is
currently not
approved for use in
the United States.
For
distributors outside
of the U.S.,
click here.
For product
literature
click here.
|
 |
|
|
|
|
|
The
generally cleared indication for the ResQPOD is a temporary increase
in blood circulation during emergency care, hospital, clinic and
home use.
Research is ongoing in the United States to evaluate the long-term
benefit of the ResQPOD for indications related to patients suffering
from cardiac arrest.
For more information on completed
clinical studies click here. The references on this website are not
intended to imply specific outcome-based claims not yet cleared by the
US Food and Drug Administration.
|
|
|
